Emcure Pharmaceuticals

2024 - 7 - 2

Shark Tank Investor Namita Thapar's Mega 293x Return on Emcure Pharma IPO!

emcure pharmaceuticals ipo Emcure Pharmaceuticals IPO - Namita Thapar - Pharmaceutical Industry - Shark Tank - Stock Market - emcure pharmaceuticals ipo

Exciting news as Namita Thapar gears up to make a whopping 293-fold return on her Emcure Pharmaceuticals investment in the upcoming IPO. Read more!

Emcure Pharmaceuticals is making headlines with its highly anticipated IPO that is set to bring in a significant sum for Shark Tank's very own Namita Thapar. With a price band of Rs 960 - Rs 1008 per share, Thapar is on track to achieve a remarkable 293-fold return on her investment at the upper end of the band. The IPO, scheduled to start tomorrow, is expected to see Thapar selling around 12.68 lakh shares, potentially gaining an impressive ₹127.87 crore.

In the world of investments and IPOs, Emcure Pharmaceuticals Ltd is a hot topic of discussion. The exclusive details of the IPO are creating a buzz as investors evaluate the opportunity it presents. As Thapar gears up to offload a partial stake through the IPO, all eyes are on the potential financial windfall that awaits her.

Turning attention to another financial giant, Tesla, investors are faced with the dilemma of whether to buy the stock before the firm's Q2 Deliveries Report. The Tokenist's analysis provides insightful coverage on Tesla's position in the market, offering valuable insights for potential investors.

As the Emcure Pharmaceuticals IPO approaches, the excitement mounts with the opening on July 3, 2024, and the closing on July 5, 2024. With the IPO comprising fresh equity shares and an Offer For Sale (OFS), the financial world is abuzz with predictions and speculations about the outcome of this significant event.

In a surprising twist, Namita Thapar, the popular Shark Tank investor, is set to witness a staggering 293-fold return on her investment in Emcure Pharma's IPO. This remarkable feat highlights the potential for lucrative gains in the world of IPOs, showcasing the power of strategic investments and bold financial moves.

Post cover
Image courtesy of "Livemint"

Emcure Pharmaceuticals IPO: Shark Tank's Namita Thapar likely to ... (Livemint)

Emcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita Thapar, a Shark Tank India investor. Thapar to sell around ...

Post cover
Image courtesy of "Moneycontrol.com"

Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit (Moneycontrol.com)

At the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure Pharmaceuticals is set at Rs 960 - Rs 1008 per share.

Post cover
Image courtesy of "Dalal Street Investment Journal"

Evaluating Emcure Pharmaceuticals Ltd IPO opportunity; Should ... (Dalal Street Investment Journal)

In this analysis, we take a closer look at Emcure Pharmaceuticals Ltd and present you with the exclusive IPO details.

Tesla: Should You Buy the Stock Before Firm's Q2 Deliveries Report ... (Investing.com India)

Shares Analysis by The Tokenist (Timothy Fries) covering: Renault SA, Alphabet Inc Class A, Baidu Inc, Tesla Inc. Read The Tokenist (Timothy Fries)'s latest ...

Post cover
Image courtesy of "Hindustan Times"

Namita Thapar may gain ₹127 crore in Emcure Pharma IPO (Hindustan Times)

Through the IPO, Namita Thapar will offload a partial stake of about 12.68 lakh shares under the offer for sale (OFS) component.

Post cover
Image courtesy of "ET Now"

Emcure Pharmaceuticals IPO GMP: Check Price Band, Subscription ... (ET Now)

Emcure Pharmaceuticals IPO will open on July 3, 2024 and it will close on July 5, 2024. The allotment of shares is expected to be finalised on July 8, 2024, ...

Post cover
Image courtesy of "ET Now"

Emcure Pharmaceuticals IPO: Money Shark Tank fame Namita ... (ET Now)

Emcure Pharmaceuticals IPO, Emcure Pharma IPO: The IPO comprises fresh issuance of equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 ...

Post cover
Image courtesy of "People Matters"

Emcure Pharma IPO: Namita Thapar's investment could soar 293 ... (People Matters)

Shark Tank India investor Namita Thapar stands to see a staggering 293-fold return on her investment in Emcure Pharma's upcoming IPO.

Post cover
Image courtesy of "NDTV Profit"

Shark Tank's Namita Thapar Will Gain This Much From Emcure ... (NDTV Profit)

Shark Tank India judge, Namita Thapar, is set to reap substantial returns following her decision to partially divest her stake in Emcure Pharmaceuticals ...

Post cover
Image courtesy of "Moneycontrol.com"

Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi (Moneycontrol.com)

Further, the company is the largest pharmaceutical company in the gynecology and human immunodeficiency virus (“HIV”) antivirals therapeutic areas in India in ...

Post cover
Image courtesy of "CNBCTV18"

Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely ... (CNBCTV18)

Shark Tank fame Namita Thapar holds 63.39 lakh shares of Emcure Pharma, which represents a 3.5% stake in the company. She will sell 12.68 lakh Emcure shares ...

Post cover
Image courtesy of "Value Research"

Emcure Pharma IPO: All you need to know | Value Research (Value Research)

Emcure Pharmaceuticals, a generic drug maker, is launching its IPO (initial public offering) on July 3, 2024. Below's a breakdown of the company's strengths ...

Post cover
Image courtesy of "EquityPandit"

Emcure IPO Unveiled: Everything about Emcure Pharmaceuticals ... (EquityPandit)

The Emcure Pharma IPO is a book-built issue amounting to Rs 1952.03 crores. It consists of a fresh issue of 0.79 crore shares, valued at Rs 800.00 crores, ...

Post cover
Image courtesy of "NDTV Profit"

Emcure Pharmaceuticals IPO: All You Need To Know (NDTV Profit)

The public issue of the Bain Capital-backed company consists of a fresh issue of Rs 800 crore and an offer for sale of 1.14 crore equity shares.

Post cover
Image courtesy of "NDTV Profit"

Emcure Pharma Raises Rs 582 Crore From Anchor Investors Prior ... (NDTV Profit)

The company allotted 57.79 lakh shares at Rs 1,008 apiece to 48 anchor investors. ADVERTISEMENT. ICICI Prudential Pharma Healthcare and Diagnostics Fund got the ...

Post cover
Image courtesy of "IPO Watch"

Emcure Pharmaceuticals (Emcure Pharma) IPO Subscription Status ... (IPO Watch)

Emcure Pharmaceuticals (Emcure Pharma) IPO subscription status live numbers. Get latest subscription status of Emcure Pharma IPO from BSE and NSE.

Post cover
Image courtesy of "Financial Express"

Shark Tank's Namita Thapar to get Rs 128 crore from Emcure ... (Financial Express)

Emcure Pharmaceuticals IPO to open on July 03 and close on July 05. The price band has been kept in a range of Rs 960 to Rs 1008 per equity share.

Post cover
Image courtesy of "Moneycontrol.com"

Emcure Pharmaceuticals raises Rs 583 crore from anchor investors ... (Moneycontrol.com)

Emcure Pharmaceuticals IPO | Marquee global investors including Abu Dhabi Investment Authority, Goldman Sachs, and Morgan Stanley bought more than Rs 71 ...

Post cover
Image courtesy of "Business Standard"

Namita Thapar-backed Emcure Pharma IPO opens: GMP, price ... (Business Standard)

Emcure Pharmaceuticals initial public offering is set to open for subscription on Wednesday, July, 3, 2024.

Post cover
Image courtesy of "Hindustan Times"

Namita Thapar's Emcure Pharmaceuticals IPO opens today: All you ... (Hindustan Times)

Emcure IPO: The price range of the IPO is ₹960-1008 per share and investors can bid for 14 shares in one lot.

Post cover
Image courtesy of "Livemint"

Emcure Pharmaceuticals IPO opens today: GMP, subscription status ... (Livemint)

Emcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price range set at ₹960-1008 per share.

Post cover
Image courtesy of "CNBCTV18"

Emcure Pharma IPO opens today: GMP rises; should you subscribe ... (CNBCTV18)

The company is offering its shares in the fixed price band of ₹960 to ₹1,008 apiece. Investors can apply for a minimum of 14 equity shares in one lot and its ...

Post cover
Image courtesy of "News18"

Emcure Pharma IPO Opens Today: Should You Subscribe? Check ... (News18)

Emcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by Bain Capital, is set to be opened for public subscription ...

Explore the last week